SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Liliʻuokalani Synthetic CCD

PatientLiliʻuokalani
Date of birth1947-09-02
IdentifiersMRN HR-ET024-SYN; SSN (made up) 000-24-3086
Document date2026-11-01
AuthorKealani Morrison-Takeda, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Urgent visit the morning after 20 minutes of right hand weakness and word-finding difficulty: examination, ABCD2 score, ECG and same-day emergency stroke evaluation with CT, CT angiography, swallow screen and antiplatelet loading, with culturally safe care and her ʻohana present at her choice. Concerns: She wants to keep playing and composing, and fears losing the use of her right hand or her words; She wants her ʻohana involved as she chooses, and her own Native Hawaiian ways of healing respected; She wants to be told plainly what is planned and to make her own decisions. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency departmentOne tablet daily for 21 daysOral route2026-03-16 to 2026-04-06completedS
Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency departmentOne tablet dailyOral route2026-03-16 to 2026-04-20completedS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-16activeS
Losartan 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-23activeS
Apixaban 5 mg oral tablet, one tablet twice dailyOne tablet twice dailyOral route2026-04-20activeS

Procedures

ProcedureDatesStatusEvidence
Twelve-lead electrocardiogram in the clinic: sinus rhythm at 72 per minute, normal intervals, no atrial fibrillation or acute changes2026-03-16 to 2026-03-16completedS
Non-contrast CT of the head in the emergency department: no hemorrhage, no established infarct, mild age-related volume loss2026-03-16 to 2026-03-16completedS
CT angiography of the head and neck: no large-vessel occlusion or intracranial stenosis; calcified plaque at the origin of the left internal carotid artery with less than 50% narrowing; right carotid and vertebral arteries normal2026-03-16 to 2026-03-16completedS
MRI of the brain with diffusion-weighted imaging: an 8 mm acute infarct in the cortex of the left precentral gyrus; no hemorrhage; mild white matter changes of small-vessel disease2026-03-17 to 2026-03-17completedS
Transthoracic echocardiography: ejection fraction 60%, mildly enlarged left atrium, no thrombus or valve vegetation, mild mitral annular calcification, no significant valve disease2026-03-17 to 2026-03-17completedS
30-day ambulatory electrocardiographic monitor (adhesive patch with an event recorder), applied at the stroke clinic2026-03-17 to 2026-03-17completedS
Advance care planning conversation, about 25 minutes, with her consent and with the members of her ʻohana she invited2026-07-13 to 2026-07-13completedS

Immunizations

DateVaccineStatusEvidence
2026-07-13Pneumococcal conjugate vaccine PCV20completedS
2026-07-13Respiratory syncytial virus vaccine, single dosecompletedS
2026-08-24Recombinant zoster vaccine, dose 1 of 2completedS
2026-08-24Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She wants to keep playing and composing, and fears losing the use of her right hand or her wordsactiveS
She wants her ʻohana involved as she chooses, and her own Native Hawaiian ways of healing respectedactiveS
She wants to be told plainly what is planned and to make her own decisionsactiveS

Assessment

Most recent measures: Total score [NIH Stroke Scale] 0 on 2026-03-17; Hemoglobin [Mass/volume] in Blood 12.7 on 2026-08-24; Platelets [#/volume] in Blood by Automated count 226 on 2026-08-24; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-08-24; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-08-24; Creatinine [Mass/volume] in Serum or Plasma 0.88 on 2026-08-24; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 67 on 2026-08-24; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-08-24; INR in Platelet poor plasma by Coagulation assay 1 on 2026-03-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-03-16; Cholesterol [Mass/volume] in Serum or Plasma 134 on 2026-08-24; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 on 2026-08-24; Cholesterol in HDL [Mass/volume] in Serum or Plasma 57 on 2026-08-24; Triglyceride [Mass/volume] in Serum or Plasma 90 on 2026-08-24; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 2026-04-20; Left ventricular Ejection fraction 60 on 2026-03-17; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 37 on 2026-03-17; Total score [MoCA] 27 on 2026-08-24; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-07-13; Modified rankin scale 1 on 2026-06-15; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-06-15; Total score [Mini-Cog] 5 on 2026-07-13; Total score [AUDIT-C] 1 on 2026-07-13 [S]

Strengths and supports: Strengths, supports and purpose: her music, her faith, her ʻohana, her work for the welfare of Hawaiian children, and a steadfast, composed manner [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0resolvedprovisional G45.9S — Synthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms.
Minor ischemic stroke: a small acute infarct in the cortex of the left precentral gyrus (left middle cerebral artery territory) on diffusion MRI, embolic in pattern, with full recovery (NIH Stroke Scale 0); source found to be paroxysmal atrial fibrillation; synthetic modern episode linked to her documented death from a strokeactiveconfirmed I63.412S — Synthetic modern diagnosis made at the stroke clinic the day after the visit; the 1917 cause of death remains D.
Hypertension: told of borderline readings in past years and not treated; 156/88 mmHg at intakeactiveconfirmed I10S — Synthetic risk factor; no blood pressure from her lifetime is recorded in the cited sources.
Paroxysmal atrial fibrillation found on 30-day ambulatory monitoring after the stroke (six episodes, the longest 3 hours 10 minutes; burden about 3%); CHA2DS2-VASc 6, HAS-BLED 2activeconfirmed I48.0S — Synthetic finding on prolonged rhythm monitoring at five weeks.
Anterior nosebleed from the left side of the nasal septum four weeks after starting apixaban, stopped with pressure; hemoglobin unchanged; resolvedresolvedconfirmed R04.0S — Synthetic intercurrent problem at an unscheduled visit; a common minor bleed on an anticoagulant, not a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-16Total score [NIH Stroke Scale]0{score}S
2026-03-16Hemoglobin [Mass/volume] in Blood12.8g/dL11.6-15 g/dLNormalS
2026-03-16Platelets [#/volume] in Blood by Automated count23210*3/uL150-400 10*3/uLNormalS
2026-03-16Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-03-16Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-16Creatinine [Mass/volume] in Serum or Plasma0.82mg/dL0.59-1.04 mg/dLNormalS
2026-03-16Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M73mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-16Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
2026-03-16INR in Platelet poor plasma by Coagulation assay1{INR}0.8-1.2NormalS
2026-03-16Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-03-16Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
2026-03-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation132mg/dLGoal below 70 mg/dL after ischemic strokeHighS
2026-03-16Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=50 mg/dLNormalS
2026-03-16Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
2026-03-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma16U/L7-35 U/LNormalS
2026-03-17Total score [NIH Stroke Scale]0{score}S
2026-03-17Left ventricular Ejection fraction60%50-70%NormalS
2026-03-17Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area37mL/m2<=34 mL/m²HighS
2026-03-17Total score [MoCA]26{score}S
2026-03-17Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-04-20Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-04-20Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-04-20Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.59-1.04 mg/dLNormalS
2026-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M69mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-20Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-04-20Hemoglobin [Mass/volume] in Blood12.7g/dL11.6-15 g/dLNormalS
2026-04-20Platelets [#/volume] in Blood by Automated count22810*3/uL150-400 10*3/uLNormalS
2026-04-20Cholesterol [Mass/volume] in Serum or Plasma138mg/dL<=199 mg/dLNormalS
2026-04-20Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation64mg/dLGoal below 70 mg/dL after ischemic strokeNormalS
2026-04-20Cholesterol in HDL [Mass/volume] in Serum or Plasma56mg/dL>=50 mg/dLNormalS
2026-04-20Triglyceride [Mass/volume] in Serum or Plasma92mg/dL<=149 mg/dLNormalS
2026-04-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
2026-05-18Hemoglobin [Mass/volume] in Blood12.5g/dL11.6-15 g/dLNormalS
2026-05-18Platelets [#/volume] in Blood by Automated count23010*3/uL150-400 10*3/uLNormalS
2026-06-15Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-06-15Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-06-15Creatinine [Mass/volume] in Serum or Plasma0.84mg/dL0.59-1.04 mg/dLNormalS
2026-06-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M71mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-15Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-06-15Hemoglobin [Mass/volume] in Blood12.6g/dL11.6-15 g/dLNormalS
2026-06-15Modified rankin scale1{score}S
2026-06-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-08-24Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-08-24Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-08-24Creatinine [Mass/volume] in Serum or Plasma0.88mg/dL0.59-1.04 mg/dLNormalS
2026-08-24Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-08-24Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-08-24Hemoglobin [Mass/volume] in Blood12.7g/dL11.6-15 g/dLNormalS
2026-08-24Platelets [#/volume] in Blood by Automated count22610*3/uL150-400 10*3/uLNormalS
2026-08-24Cholesterol [Mass/volume] in Serum or Plasma134mg/dL<=199 mg/dLNormalS
2026-08-24Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation62mg/dLGoal below 70 mg/dL after ischemic strokeNormalS
2026-08-24Cholesterol in HDL [Mass/volume] in Serum or Plasma57mg/dL>=50 mg/dLNormalS
2026-08-24Triglyceride [Mass/volume] in Serum or Plasma90mg/dL<=149 mg/dLNormalS
2026-08-24Total score [MoCA]27{score}S
2026-07-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-07-13Total score [Mini-Cog]5{score}S
2026-07-13Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-16Body height160cmS
2026-03-16Body weight58kgS
2026-03-16Body mass index (BMI) [Ratio]22.7kg/m2S
2026-03-16Systolic blood pressure156mm[Hg]S
2026-03-16Diastolic blood pressure88mm[Hg]S
2026-03-16Heart rate72/minS
2026-03-16Respiratory rate16/minS
2026-03-16Body temperature36.6CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-03-17Body height160cmS
2026-03-17Body weight58kgS
2026-03-17Body mass index (BMI) [Ratio]22.7kg/m2S
2026-03-17Systolic blood pressure148mm[Hg]S
2026-03-17Diastolic blood pressure86mm[Hg]S
2026-03-17Heart rate70/minS
2026-03-17Respiratory rate16/minS
2026-03-17Body temperature36.7CelS
2026-03-17Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-04-20Body height160cmS
2026-04-20Body weight57.8kgS
2026-04-20Body mass index (BMI) [Ratio]22.6kg/m2S
2026-04-20Systolic blood pressure130mm[Hg]S
2026-04-20Diastolic blood pressure78mm[Hg]S
2026-04-20Heart rate74/minS
2026-04-20Respiratory rate16/minS
2026-04-20Body temperature36.6CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-06-15Body height160cmS
2026-06-15Body weight57.6kgS
2026-06-15Body mass index (BMI) [Ratio]22.5kg/m2S
2026-06-15Systolic blood pressure126mm[Hg]S
2026-06-15Diastolic blood pressure74mm[Hg]S
2026-06-15Heart rate70/minS
2026-06-15Respiratory rate16/minS
2026-06-15Body temperature36.6CelS
2026-06-15Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-24Body height160cmS
2026-08-24Body weight57.8kgS
2026-08-24Body mass index (BMI) [Ratio]22.6kg/m2S
2026-08-24Systolic blood pressure124mm[Hg]S
2026-08-24Diastolic blood pressure74mm[Hg]S
2026-08-24Heart rate70/minS
2026-08-24Respiratory rate16/minS
2026-08-24Body temperature36.5CelS
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-18Body height160cmS
2026-05-18Body weight57.8kgS
2026-05-18Body mass index (BMI) [Ratio]22.6kg/m2S
2026-05-18Systolic blood pressure128mm[Hg]S
2026-05-18Diastolic blood pressure76mm[Hg]S
2026-05-18Heart rate78/minS
2026-05-18Respiratory rate16/minS
2026-05-18Body temperature36.6CelS
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-13Body height160cmS
2026-07-13Body weight57.6kgS
2026-07-13Body mass index (BMI) [Ratio]22.5kg/m2S
2026-07-13Systolic blood pressure124mm[Hg]S
2026-07-13Diastolic blood pressure72mm[Hg]S
2026-07-13Heart rate68/minS
2026-07-13Respiratory rate16/minS
2026-07-13Body temperature36.6CelS
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-03-16Urgent visit the morning after 20 minutes of right hand weakness and word-finding difficulty: examination, ABCD2 score, ECG and same-day emergency stroke evaluation with CT, CT angiography, swallow screen and antiplatelet loading, with culturally safe care and her ʻohana present at her choicefinishedS
2026-03-17Stroke clinic the next morning: diffusion MRI, echocardiogram, 30-day rhythm monitor, cognition screen and vascular neurology consultationfinishedS
2026-04-20Five-week review: rhythm monitor result, anticoagulation decision, lipids, kidney function and blood pressurefinishedS
2026-06-15Three-month review after the stroke: function, mood, blood pressure, apixaban safety and fallsfinishedS
2026-08-24Five-month review: blood pressure, lipids, apixaban safety, cognition and plans for the months aheadfinishedS
2026-05-18Same-day sick visit for a nosebleed on apixabanfinishedS
2026-07-13Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Culturally safe, trauma-informed care: address her as Liliʻuokalani, as she asked; take time; explain each test and treatment plainly before it is done; involve her ʻohana as she chooses while she makes the decisions; acknowledge the history of the overthrow when she raises it, without probingcompletedGL-AHA-PCAS-2021, GL-KEOLAMAMO, GL-PL103-150S
Same-day emergency stroke evaluation today (CT, CT angiography of the head and neck, swallow screen and laboratory tests), then vascular neurology consultation at the rapid-access stroke clinic tomorrow morning, with diffusion MRI and an echocardiogramcompletedGL-AHA-STROKE-2021, GL-ABCD2-2007, GL-CMID-2026S
Dual antiplatelet therapy started within 24 hours of onset once CT excluded bleeding: aspirin 325 mg and clopidogrel 300 mg loading doses, then aspirin 81 mg and clopidogrel 75 mg daily for 21 days, then a single antiplatelet; stop antiplatelets if anticoagulation is startedcompletedGL-AHA-STROKE-2021, GL-POINT-2018, GL-CHANCE-2013S
Atorvastatin 40 mg daily, a high-intensity statin, with a lipid panel at four to twelve weeks; LDL goal below 70 mg/dLcompletedGL-AHA-STROKE-2021, GL-CMID-2026S
Bedside swallow screen before any food or drink, a cognition screen (MoCA) at the stroke clinic, a depression screen, and a falls assessmentcompletedGL-AHA-STROKE-2021, GL-AHA-PCAS-2021, GL-CMID-2026S
BE FAST: balance, eyes, face, arm, speech, time to call 911; call 911 at once for any new symptom, even if it passes, and do not drive herselfcompletedGL-CDC-BEFAST, GL-AHA-STROKE-2021S
Native Hawaiian healing alongside clinic care, if she wishes: lomilomi through Ke Ola Mamo, a Native Hawaiian Health Care System, with the practitioner told that she takes blood thinners, and hoʻoponopono with her ʻohana as they choose; the clinic asks nothing further about her practicescompletedGL-KEOLAMAMOS
Blood pressure: home readings twice daily for a week; if the average is 130/80 mmHg or higher after the first week, start losartan 25 mg daily, with potassium and creatinine two weeks later; target below 130/80 mmHgcompletedGL-AHA-STROKE-2021, GL-AHA-HTN-2025, GL-CMID-2026S
Rhythm monitoring for atrial fibrillation for 30 days with an ambulatory patch, because the stroke is embolic in pattern; if atrial fibrillation is found, stop antiplatelets and start a direct oral anticoagulantcompletedGL-AHA-STROKE-2021, GL-ACC-ARRH-2024, GL-AF-2023S
Apixaban 5 mg twice daily for paroxysmal atrial fibrillation (CHA2DS2-VASc 6, HAS-BLED 2), with clopidogrel stopped; blood count and kidney function before starting and about every five to six months at her age and kidney function; bleeding precautions, no anti-inflammatory pain medicines, and a falls plancompletedGL-AF-2023, GL-AHA-STROKE-2021, GL-CMID-2026S
Laboratory tests drawn at clinic visits, or at home by the clinic's nurse, instead of separate trips to the laboratorycompletedGL-CMID-2026S
Daily walking, the foods she already eats with less salted and preserved food, alcohol kept to rare occasions, and no smokingcompletedGL-AHA-STROKE-2021, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
No recurrent stroke or transient ischemic attack2026-08-24activeNone in five months on dual antiplatelets, then apixabanS
LDL cholesterol below 70 mg/dL2026-04-20completed132 to 64 mg/dL on atorvastatin 40 mgS
Blood pressure below 130/80 mmHg at home and in the clinic2026-06-15completed126/74 in the clinic; home average 124/72S
Anticoagulation that is safe and taken as prescribed, without major bleeding2026-08-24activeApixaban 5 mg twice daily from five weeks; one minor nosebleed, controlled at home and in the clinic; no missed dosesS
Keep playing the piano and composing2026-06-15completedPlaying daily; modified Rankin Scale 1 at three monthsS

Functional Status

Mental Status